Xubix

Xubix

Sibrafiban, see there.
Mentioned in ?
References in periodicals archive ?
Roche Holding AG reported that Xubix, an oral platelet IIb/IIIa antagonist discovered jointly with Genentech and aimed at cutting the risk of cardiac events, showed no benefit over aspirin in a Phase III trial.
Xubix was discovered in a joint discovery program between Genentech and Roche.